IBD Community Advisory Panel
We’d like to hear from you. Join Qu’s IBD Community Advisory Panel.
Qu Biologics recognizes the essential value and importance of the input and perspectives of people living with inflammatory bowel disease (IBD) and their caregivers in the design of our treatments and clinical trials. We are establishing an IBD Community Advisory Panel to broaden our connection with the IBD community and further our understanding of their needs, concerns and insights as it relates to IBD treatment and clinical trial design. If you believe you can provide some valuable insight that can help to make us a better patient-centered company, we’d like to hear from you.
Qu Biologics is a biotechnology company developing Site Specific Immunomodulators (SSIs), as investigational treatments for cancer and immune-related diseases such as Crohn’s disease and ulcerative colitis. SSIs are designed to restore the body’s normal immune function and correct the underlying dysfunctional immune response.
Who can join?
If you are living with IBD or caring for someone living with IBD, we’d like to hear from you. Members must be adults and English-speaking.
What will be required as a member of the IBD Community Advisory Panel?
Panel members will participate in teleconference meetings 2-4 times a year and provide insight on experiences living with inflammatory bowel disease. Each teleconference call will be 90 minutes long. IBD Community Advisory Panel members will be asked to serve as members for a period of one year, with an option to renew. Please note that this is a volunteer role.
How do I get involved?
To join the IBD Advisory Panel, please complete the application form below. We will contact you shortly after you’ve completed the application. Information will not be shared with third parties.